CRISPR Therapeutics Announces Second Quarter 2017 Financial Results and Provides Business Update
Aug 10, 2017 20:35 pm UTC| Business
On track to file for clinical trial application (CTA) for lead program in beta-thalassemia in 2017Rapid progress in immuno-oncology including a lead program in allogeneic CAR-T cell therapyExpanded foundational and...
Marin Software Announces Second Quarter 2017 Financial Results
Aug 10, 2017 20:35 pm UTC| Business
SAN FRANCISCO, Aug. 10, 2017 -- Marin Software Incorporated (NYSE:MRIN), a leading provider of cross-channel, cross-device, enterprise marketing software for advertisers and agencies, today announced financial results...
Tyson Foods, Inc. Announces Quarterly Dividend
Aug 10, 2017 20:34 pm UTC| Business
SPRINGDALE, Ark., Aug. 10, 2017 -- The Board of Directors of Tyson Foods, Inc. (NYSE:TSN), at a meeting on August 10, 2017, declared a quarterly dividend of $0.225 per share on Class A common stock and $0.2025 per share...
African Bicycle Contribution Foundation adds Renee Chenault-Fattah to its Board of Directors
Aug 10, 2017 20:33 pm UTC| Business
Philadelphia, PA, Aug. 10, 2017 -- The African Bicycle Contribution Foundation (ABCF), a Philadelphia-based, 501 (c)3 corporation which is committed to generating funding for the purchase and distribution of free bamboo...
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against GlobalSCAPE, Inc.
Aug 10, 2017 20:32 pm UTC| Business
OKLAHOMA CITY, Aug. 10, 2017 -- Federman Sherwood announces that on August 9, 2017, a class action lawsuit was filed in the United States District Court for the Western District of Texas against GlobalSCAPE, Inc....
EDAP-TMS to Announce Second Quarter 2017 Financial Results on Wednesday, August 23, 2017
Aug 10, 2017 20:31 pm UTC| Business
PRESS RELEASE Contact: Blandine ConfortInvestor Relations / Legal AffairsEDAP TMS SA+33 4 72 15 31 [email protected] Investors:Rich CockrellCG [email protected] EDAP-TMS to Announce...
PLx Pharma Inc. Reports Second Quarter 2017 Results
Aug 10, 2017 20:30 pm UTC| Business
HOUSTON, Aug. 10, 2017 -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81...
How the US–India tariff truce boosts major Indian industries, Surat to Pharma